Aug 03, 2020 / 12:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by. And welcome to the Ligand Pharmaceuticals Q2 2020 Earnings Conference Call.
(Operator Instructions)
I would now like to hand the conference over to Patrick O'Brien, SVP of Investor Relations. Sir, the floor is yours.
Patrick O'Brien - Ligand Pharmaceuticals Incorporated - SVP of IR
Thank you, Carmen. And welcome to Ligand's second quarter of 2020 financial results and business update conference call. Consistent with recommendations for social distancing, all of our speakers for today's calls are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO. We will be using slides to guide our discussion today.
We also will use non-GAAP financial measures, and some of our statements will be forward-looking. Additional information concerning risk factors and other matters concerning Ligand can be found in our Ligand's earnings press release, slides and our periodic filings with the SEC. Ligand undertakes no
Q2 2020 Ligand Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers